Nosocomial outbreak of vancomycin-resistant

Humans Vancomycin Enterococcus faecium / genetics Cross Infection / epidemiology Switzerland / epidemiology Vancomycin-Resistant Enterococci / genetics Disease Outbreaks Hospitals, University Gram-Positive Bacterial Infections / epidemiology
VRE Vancomycin resistant Enterococcus faecium Whole genome sequencing antibiotic resistance infection prevention and control nosocomial outbreak outbreak management

Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
12 2022
Historique:
entrez: 25 1 2023
pubmed: 26 1 2023
medline: 27 1 2023
Statut: ppublish

Résumé

A large clonal outbreak caused by vancomycin-resistant

Identifiants

DOI: 10.2807/1560-7917.ES.2022.27.48.2200285 PMID: 36695463 PMC: PMC9716646
pubmed: 36695463
doi: 10.2807/1560-7917.ES.2022.27.48.2200285
pmc: PMC9716646
doi:

Substances chimiques

Vancomycin 6Q205EH1VU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Drug Resist Updat. 2020 Dec;53:100732
pubmed: 33189998
Sci Rep. 2018 Apr 19;8(1):6274
pubmed: 29674657
Antibiotics (Basel). 2021 Jan 22;10(2):
pubmed: 33499102
Braz J Microbiol. 2020 Dec;51(4):1607-1613
pubmed: 32783169
PLoS One. 2013 Sep 27;8(9):e75658
pubmed: 24086603
Lancet Infect Dis. 2007 Apr;7(4):282-8
pubmed: 17376385
Swiss Med Wkly. 2012 May 22;142:w13540
pubmed: 22618895
Antimicrob Resist Infect Control. 2022 Jan 28;11(1):19
pubmed: 35090563
Rev Med Suisse. 2018 Apr 11;14(602):791-794
pubmed: 29658219
Front Public Health. 2021 Jun 10;9:599285
pubmed: 34178909
PeerJ. 2017 Jan 24;5:e2916
pubmed: 28149688
Infect Control Hosp Epidemiol. 2017 Feb;38(2):203-215
pubmed: 27825401
Antimicrob Resist Infect Control. 2018 Mar 22;7:44
pubmed: 29588851
GMS Hyg Infect Control. 2021 Mar 17;16:Doc13
pubmed: 33796441
Rev Med Suisse. 2013 Apr 24;9(383):890-3
pubmed: 23697084
Hong Kong Med J. 2017 Apr;23(2):140-9
pubmed: 28232642
J Clin Microbiol. 2016 Oct;54(10):2436-47
pubmed: 27147728
Antimicrob Agents Chemother. 2004 Feb;48(2):556-60
pubmed: 14742209
Infect Control Hosp Epidemiol. 2022 Sep 16;:1-7
pubmed: 36111457
Infect Dis Health. 2019 May;24(2):82-91
pubmed: 30638872
J Antimicrob Chemother. 2020 Jun 1;75(6):1398-1404
pubmed: 32083651
Swiss Med Wkly. 2018 Dec 15;148:w14693
pubmed: 30552858
Euro Surveill. 2020 Sep;25(35):
pubmed: 32885778
Euro Surveill. 2018 Jul;23(29):
pubmed: 30043725
J Hosp Infect. 2022 Apr;122:108-114
pubmed: 35090955
Antimicrob Resist Infect Control. 2019 Jan 17;8:16
pubmed: 30675343
Antimicrob Resist Infect Control. 2021 Feb 18;10(1):38
pubmed: 33602300
Infect Control Hosp Epidemiol. 2016 Jan;37(1):26-35
pubmed: 26434609
J Hosp Infect. 2018 Dec;100(4):e216-e225
pubmed: 29475013
Eur J Clin Microbiol Infect Dis. 2019 Jun;38(6):1163-1170
pubmed: 30888549

Auteurs

Vanja Piezzi (V)

Department of Infectious Diseases, University Hospital Bern, University of Bern, Bern, Switzerland.

Nasstasja Wassilew (N)

Department of Infectious Diseases, University Hospital Bern, University of Bern, Bern, Switzerland.

Andrew Atkinson (A)

Department of Infectious Diseases, University Hospital Bern, University of Bern, Bern, Switzerland.

Stéphanie D'Incau (S)

Department of Infectious Diseases, Lucerne Cantonal Hospital, Lucerne, Switzerland.

Tanja Kaspar (T)

Department of Infectious Diseases, University Hospital Bern, University of Bern, Bern, Switzerland.

Helena Mb Seth-Smith (HM)

Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland.
Division of Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland and Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.

Carlo Casanova (C)

Institute for Infectious Diseases, University of Bern, Bern, Switzerland.

Pascal Bittel (P)

Institute for Infectious Diseases, University of Bern, Bern, Switzerland.

Philipp Jent (P)

Department of Infectious Diseases, University Hospital Bern, University of Bern, Bern, Switzerland.

Rami Sommerstein (R)

Department Health Sciences and Medicine, Clinic St. Anna, University of Lucerne, Lucerne, Switzerland.
Department of Infectious Diseases, University Hospital Bern, University of Bern, Bern, Switzerland.

Niccolò Buetti (N)

INSERM, IAME, Université Paris-Cité, Paris, France.
Infection Control Programme, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland.

Jonas Marschall (J)

Division of Infectious Diseases, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, United States.
Department of Infectious Diseases, University Hospital Bern, University of Bern, Bern, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Nosocomial outbreak of vancomycin-resistant
questionsmedicales.fr › Acides aminés, peptides et protéines › Peptides › Glycopeptides › Vancomycine › Nosocomial outbreak of vancomycin-resistant
questionsmedicales.fr › Bactéries › Bactéries à Gram positif › Lactobacillales › Enterococcaceae › Enterococcus › Enterococcus faecium › Nosocomial outbreak of vancomycin-resistant
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Maladie iatrogène › Infection croisée › Nosocomial outbreak of vancomycin-resistant
questionsmedicales.fr › Régions géographiques › Europe › Suisse › Nosocomial outbreak of vancomycin-resistant
questionsmedicales.fr › Bactéries › Bactéries à Gram positif › Lactobacillales › Enterococcaceae › Enterococcus › Entérocoques résistants à la vancomycine › Nosocomial outbreak of vancomycin-resistant
questionsmedicales.fr › Environnement et santé publique › Santé publique › Épidémies de maladies › Nosocomial outbreak of vancomycin-resistant
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Établissements de santé › Hôpitaux › Hôpitaux d'enseignement › Hôpitaux universitaires › Nosocomial outbreak of vancomycin-resistant
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram positif › Nosocomial outbreak of vancomycin-resistant